These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18762707)

  • 1. Practical risk prediction tools for coronary heart disease in mild to moderate hypercholesterolemia in Japan: originated from the MEGA study data.
    Teramoto T; Ohashi Y; Nakaya N; Yokoyama S; Mizuno K; Nakamura H;
    Circ J; 2008 Oct; 72(10):1569-75. PubMed ID: 18762707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radial arterial wave reflection is associated with the MEGA risk prediction score, an indicator of coronary heart disease risk, in middle-aged men with mild to moderate hypercholesterolemia.
    Otsuka T; Kawada T; Ibuki C; Kusama Y
    J Atheroscler Thromb; 2010 Jul; 17(7):688-94. PubMed ID: 20467193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the effect of pravastatin and risk factors for coronary heart disease in Japanese patients with hypercholesterolemia.
    Ishikawa T; Mizuno K; Nakaya N; Ohashi Y; Tajima N; Kushiro T; Teramoto T; Uchiyama S; Nakamura H;
    Circ J; 2008 Oct; 72(10):1576-82. PubMed ID: 18756039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial.
    Uchiyama S; Nakaya N; Mizuno K; Ohashi Y; Tajima N; Kushiro T; Teramoto T; Nakamura H;
    J Neurol Sci; 2009 Sep; 284(1-2):72-6. PubMed ID: 19423132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combination of Elevated Triglycerides and Abnormal Fasting Glucose Increases Risk of Cerebral Infarction in Patients With Mild to Moderate Hypercholesterolemia: A Post Hoc Analysis of the MEGA Study.
    Nakagami T; Nishimura R; Sone H; Tajima N
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):169-73. PubMed ID: 24906541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
    Tajima N; Kurata H; Nakaya N; Mizuno K; Ohashi Y; Kushiro T; Teramoto T; Uchiyama S; Nakamura H;
    Atherosclerosis; 2008 Aug; 199(2):455-62. PubMed ID: 18635188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and cancer events in hyper-high-density lipoprotein cholesterolemic patients: a post hoc analysis of the MEGA study.
    Nakamura H; Mizuno K;
    Lipids Health Dis; 2014 Aug; 13():133. PubMed ID: 25135178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lipid parameters to predict cardiovascular events in Japanese mild-to-moderate hypercholesterolemic patients with and without type 2 diabetes: Subanalysis of the MEGA study.
    Sone H; Nakagami T; Nishimura R; Tajima N;
    Diabetes Res Clin Pract; 2016 Mar; 113():14-22. PubMed ID: 26972955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of LDL-C-related parameters to predict cardiovascular risk and effect of pravastatin in mild-to-moderate hypercholesterolemia.
    Mizuno K; Nakaya N; Teramoto T; Yokoyama S; Ohashi Y; Ueki A; Takahashi S; Kubota Y; Nakamura H
    J Atheroscler Thromb; 2012; 19(2):176-85. PubMed ID: 22129522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effect of pravastatin on the development of hypertension in patients with hypercholesterolemia: A post-hoc analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
    Otsuka T; Mizuno K; Shinozaki T; Kachi Y; Nakamura H
    J Clin Lipidol; 2017; 11(4):998-1006. PubMed ID: 28655522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pravastatin for cardiovascular event primary prevention in patients with mild-to-moderate hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
    Kushiro T; Mizuno K; Nakaya N; Ohashi Y; Tajima N; Teramoto T; Uchiyama S; Nakamura H;
    Hypertension; 2009 Feb; 53(2):135-41. PubMed ID: 19104004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of coronary heart disease using risk factor categories.
    Wilson PW; D'Agostino RB; Levy D; Belanger AM; Silbershatz H; Kannel WB
    Circulation; 1998 May; 97(18):1837-47. PubMed ID: 9603539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of coronary heart disease risk factors in Nigerians with systemic hypertension.
    Opadijo OG; Akande AA; Jimoh AK
    Afr J Med Med Sci; 2004 Jun; 33(2):121-5. PubMed ID: 15565928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
    Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
    Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A coronary heart disease risk score based on patient-reported information.
    Mainous AG; Koopman RJ; Diaz VA; Everett CJ; Wilson PW; Tilley BC
    Am J Cardiol; 2007 May; 99(9):1236-41. PubMed ID: 17478150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of serum total cholesterol and other risk factors to risk of coronary events in middle-aged and elderly Japanese men with hypercholesterolemia: the Kyushu Lipid Intervention Study.
    Iwashita M; Matsushita Y; Sasaki J; Arakawa K; Kono S;
    Circ J; 2004 May; 68(5):405-9. PubMed ID: 15118279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study.
    Wilson PW; Anderson KM; Castelli WP
    Am J Med; 1991 Jan; 90(1):11-6. PubMed ID: 1986576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.